Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citis 2025 Global Healthcare Conference in December
November 21, 2025 16:30 ET Â | Source: Teva Pharmaceutical Industries Ltd TEL…
Pluri Subsidiary Coffeesai and Instituto del Caf de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico
October 08, 2025 09:00 ET Â | Source: Pluri Inc. State-backed collaboration outlines…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term…